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Exercise Testing Three Days After Onset 
of Acute Myocardial Infarction 
ERIC J. TOPOL, MD, JACK E. JUNI, MD, WILLIAM W. O’NEILL, MD, 
JOHN M. NICKLAS, MD, MICHAEL J. SHEA, MD, KAREN BUREK, BS, RN, 
and BERTRAM PITT, MD 
To determine the feasibility and predictive value of 
early exercise testing 72 hours after acute myocar- 
dial infarction, 109 consecutive patients who re- 
ceived reperfusion therapy were prospectively eval- 
uated. In the group studied, in 87 (80 % ) the course 
was uncomplicated 3 days after admission, as de- 
fined by a lack of congestive heart failure, arrhyth- 
mias and angina, and 53 patients (49% ) performed 
heart rate-limited (140 beats/min) treadmill exer- 
cjse. These patients exercised for 7.9 f 3.4 min- 
utes, achieving a heart rate of 129 f 11 beats/min 
and a systolic blood pressure of 151 f 27 mm Hg. 
The exercise test was not accompanied by any pro- 
tracted ischemia, infarction or significant arrhyth- 
mias. Accompanying tomographic thallium-201 
scintigraphy demonstrated a reversible perfusion de- 
fect in 14 patients (26% ), no evidence for ische- 
mia in 36 patients (69% ) and an equivocal result in 
3 patients (6 % ). CM the 14 patients with a positive 
exercise-thallium test result, 4 had an adverse clini- 
cal outcome of either reinfarction, postinfarction an- 
gina or ventricular tachycardia during hospital days 
4 to 10; an adverse in-hospital outcome was not 
seen in the 40 patients with a negative exercise- 
thallium test result (p = 0.009). Thus, early exer- 
cise testing after acute myocardial infarction is safe 
in selected patients with an uncomplicated course 
and the test is predictive of in-hospital clinical 
outcomes. 
(Am J Cardiol 1987;60:958-962) 
s ince the first early (7 weeks) exercise test after acute 
myocardial infarction (AMI) reported by Torkelson in 
1964,1 our approach to the patient with AM1 has been 
revamped. In the past 5 years, it has become standard 
care to perform a low-level exercise treadmill test in 
suitable patients before hospital discharge approxi- 
mately 7 to 10 days after admission.z-7 Concurrent with 
this practice, interventional strategies to achieve myo- 
cardial reperfusion with thrombolytic agents and me- 
chanical recanalization have become popular.8JJ The 
strategies of thrombolysis and coronary angioplasty in- 
cur a significant expense, which is not offset except for 
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the potential for mortality reduction or improved qual- 
ity of life. In patients receiving very early reperfusion 
therapy, limitation of infarct size has been demon- 
stratedlOJ1 and the possibility for earlier mobilization 
and hospital discharge is suggested. This study deter- 
mines the safety, feasibility and predictive value of 
exercise testing with scintigraphy 3 days after AMI. A 
secondary objective was to consider whether throm- 
bolysis and angioplasty lead to an increased likelihood 
for a patient to perform an early exercise test and have 
a negative result. 
Methods 
Patient selectign: Between September 1985 and 
March 1986, 109 consecutive patients with AM1 who 
received reperfusion therapy were admitted to the 
University of Michigan Hospital. The diagnosis of 
AM1 was determined by the clinical history, elevation 
in serial creatine kinase isoenzyme levels and typical 
electrocardiographic changes. All patients with an un- 
complicated AM1 were asked to participate in this 
study and informed consent was obtained before exer- 
cise testing. The study population consisted of all 
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patients who received an acute intervention, includ- 
ing coronary angioplasty with or without thromboly- 
sis, and thrombolytic therapy alone. All patients un- 
derwent emergency cardiac catheterization within 6 
hours of the onset of symptoms. Patients with trans- 
mural as well as non-Q-wave AM1 were included. 
Approval to conduct the study was granted by the insti- 
tutional review board. The protocol design is shown in 
Figure 1. 
An uncomplicated AM1 was defined as the absence 
of the following criteria at 3 days after admission: (11 
postinfarction angina defined as rest pain lasting more 
than 20 minutes associated with electrocardiographic 
changes; (21 congestive heart failure, diagnosed by 
a new requirement for digoxin and furosemide thera- 
py or bibasilar rales half way up the posterior lung 
fields, or a ventricular gallop; (31 left ventricular ejec- 
tion fraction less than 35% as determined by left ven- 
triculography or radionuclide angiography; (41 systolic 
blood pressure less than 90 mm Hg; (51 higher than 
Lown class 3 ventricular arrhythmia12; and (6) high- 
grade (Mobitz II or third-degree) atrioventricular 
block. 
Exercise testing: On the morning of the fourth hos- 
pital day, patients were brought to the exercise lab- 
oratory where a treadmill exercise test with accom- 
panying 12-lead electrocardiography and tomographic 
thallium scintigraphy was performed.13 The exercise 
treadmill protocol was: stage l-2 mph, 10% grade for 
3 minutes; stage 2-3.0 mph at 12% grade for 3 min- 
utes; stage 3-3.0 mph at 14% grade for 3 minutes; 
stage 4-3.0 mph at 16% grade for 3.0 minutes; stage 
5-3.0 mph at 18% grade for 3.0 minutes; and, if neces- 
sary, stage 6-3.0 mph at 20% grade for 3 minutes. The 
workload was increased by 1 stage at the end of each 3- 
minute perod until attainment of an arbitrary target 
heart rate of 140 beats/min or development of clinical 
symptoms: angina [with accompanying electrocardio- 
graphic changes), significant dyspnea, decrease in sys- 
tolic blood pressure of more than 15 mm Hg below the 
peak value achieved in the prior stage, ventricular 
tachycardia or inability to walk due to claudication or 
generalized fatigue. One minute before terminating 
exercise, 3 mCi of intravenous thallium-201 was ad- 
ministered. Patients underwent tomographic thailium 
imaging immediately after termination of exercise. A 
redistribution set of images was acquired 3 to 4 hours 
later. 
A positive exercise response was defined as (1) 
provocation of angina; (2) horizontal or downsloping 
ST-segment depression of at least 2.0 mm below the 
baseline; or (3) a definite reversible perfusion abnor- 
mality as detected by tomographic thallium imaging. 
Thallium scintigraphy was used in conjunction with 
the exercise treadmill because of the significant per- 
sistent electrocardiographic ST- and T-wave abnor- 
malities present in most of these patients. A reversible 
perfusion abnormality resulted in a positive reading of 
the test whether or not it occurred in the per&infarct 
zone. The tomographic thallium studies were inter- 
preted by 2 investigators blinded to the patient’s clini- 
cal data and the timing of the exercise study (i.e., 4 vs 7 
TABLE 1 
Total Patients Early ETT Patients 
(n = 109) (n = 53) 
Age W 55 f 9 51 f 7 
Men (%) 85 (78%) 47 (89%) 
Q-wave AMI (%) 96 (88%) 45 (85%) 
Anterior (%) 42 (39%) 16(30%) 
Inferior (%) 61 (56%) 32(60%) 
There were no significant (p <0.05) differences in demographic charac- 
teristics in patients performing early ETT compared with the overall study 
population. 
AMI = acute myocardial infarction; ETT = exercise treadmill test. 
days). A test was defined as equivocal if there was 
ambiguity with respect to the presence or absence of a 
reversible perfusion abnormality. Patients with a neg 
ative exercise test result did not have angina, signifi- 
cant ST-segment depression or evidence of a revers- 
ible perfusion abnormality. A thallium scan with a 
fixed defect only was considered negative for the pur- 
pose of this study. 
Follow-up: The patients were followed for the du- 
ration of the hospitalization and for a 6-month period 
after leaving the hospital for adverse clinical out- 
comes. These outcomes included: (1) new onset of an- 
gina; (21 reinfarction; (3) congestive heart failure as 
previously defined; (4) need for coronary artery bypass 
surgery or percutaneous transluminal coronary angio- 
plasty; (5) ventricular tachycardia or fibrillation; and 
(6) death. After hospital discharge, follow-up data 
were obtained by outpatient visit or by telephone 
contact. 
Statistical methods: Values are expressed as mean 
f standard deviation. A Fisher exact test was used to 
determine the predictive value of-a positive exercise 
test and the differences in uncomplicated infarction 
rate, ability to perform an early treadmill test, and a 
negative result of the test between 2 groups of patients: 
those receiving thrombolytic therapy alone and those 
who underwent coronary angioplasty with or without 
thrombolysis. 
Results 
Demographics: The relevant demographic charac- 
teristics of the overall group of 109 consecutive pa- 
tients and the subset of 53 patients who underwent 
early exercise testing are listed in Table I. Fifty-six 
patients did not undergo exercise testing on day 4 for 
the following reasons: complicated infarction in 22 
[39%), inability to exercise due to heart failure or de- 
bilitated status in 16 (29%), a large inguinal hematoma 
related to cardiac catheterization and thrombolytic 
therapy in 9 (16%), noncardiac disease such as se- 
vere chronic obstructive pulmonary disease or uncon- 
trolled diabetes in 5 (9%) and refusal to participate in 
the protocol in 4 [79’0,3. 
The following modes of acute interventional thera- 
py were used in the 109 study patients: intravenous 
streptokinase (1.5 million units over 30 to 60 minutes) 
in 10 patients, intravenous tissue-type plasminogen ac- 
tivator I150 mg over 6 to 8 hours) in 26 and emergency 
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coronary angioplasty (with thrombolysis in 64 patients 
or without concurrent thrombolytic treatment in 9 pa- 
tients] in 73. At exercise testing 3 days after AMI, the 53 
patients achieved a heart rate of 129 f 11 beats/min, 
systolic blood pressure of 151 f 27 mm Hg during 7.9 f 
3.4 minutes of the treadmill protocol. The reasons for 
termination and proportion of patients, respectively, 
were: target heart rate (59%), leg fatigue or claudica- 
tion (17%), fatigue (13%), dyspnea (6%] and chest pain 
(4%). 
Exercise testing: With tomographic thallium scin- 
tigraphy, a fixed perfusion defect was identified in 51 
of the patients (96%). In 14 patients (26%), the test was 
considered positive because of a reversible perfusion 
abnormality in 13 patients and angina, 2.5 mm of ST- 
segment depression, but no reversible thallium defect 
in 1 patient (1.8%). Only 2 of 14 patients (14%) in this 
group with reversible perfusion abnormalities had an- 
gina and significant ST-segment depression. A nega- 
tive or equivocal exercise test result occurred in 36 and 
3 patients, respectively. No patient had protracted an- 
gina, infarction or arrhythmias during or within 24 
hours after the exercise test had been performed. The 
only arrhythmia observed was couplets and frequent 
ventricular premature beats in 1 patient during the 
recovery period. 
Acute intervention results: Patients who had 
emergency coronary angioplasty had a similarly high 
rate of uncomplicated AM1 and ability to perform the 
treadmill test, compared with patients treated with 
thrombolysis alone (82% vs 75%, p = 0.44, and 53% vs 
3870, p = 0.25, respectively, Figure 3). A trend toward a 
negative exercise test response was observed in those 
Uncomplicated MI at 72 hrs 
I 
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l VT, Arrhythmias Negative Positive Equivocal 
FIGURE 1. Protocol for early exercise testing 72 hours after myo- 
cardial infarction. CHF = congestive heart failure; ElT = exercise 
treadmill test; SPECT = single-photon emission computed tomogra- 
phy; TI = thallium; VT = ventricular tachycardia. 
FIGURE 2. Of 109 consecutive patients, 57 were not eligible to 
undergo exercise treadmill testing (ETT) on the fourth hospital day. 
For the 53 patients who completed the test, the results are shown at 
leff. AMI = acute myocardial infarction. 
who underwent angioplasty compared with those re- 
ceiving thrombolytic therapy alone (38% vs 22%, re- 
spectively, p = 0.15). 
Follow-up: Between the day 4 exercise test and 
hospital discharge, no adverse clinical event occurred 
in the 36 patients who had negative responses to the 
exercise thallium study. These patients were dis- 
charged from the hospital at 8 f 1 days. In the group of 
14 patients with a positive test, 1 had a reinfarction on 
day 6, 2 had rest angina and 1 patient had both new 
congestive heart failure and several runs of nonsus- 
tained ventricular tachycardia. In the positive exercise 
test group, hospital discharge was at 13 f 3 days. A 
significant difference of a positive vs a negative exer- 
cise test result for predicting in-hospital clinical out- 
comes was demonstrated (4 of 14 vs 0 of 40, respective- 
ly, P = 0.009). Of the 2 patients in whom angina 
developed, 1 underwent coronary angioplasty and 1 
had coronary artery bypass grafting. In the remaining 
12 patients with a positive stress test result, 3 had angi- 
oplasty and 1 underwent bypass surgery before leav- 
ing the hospital. Thus, the need for a revasculariza- 
tion procedure before hospital discharge was greater 
among patients with a positive test response (43%) 
than in those with a negative response (O%), but the 
results of the exercise-thallium study influenced deci- 
sion-making in some patients, 
Follow-up data on all 53 patients who underwent 
early exercise testing has been obtained at 7.1 f 0.9 
months after admission to the study. No patient in this 
group died. In 4 of the patients (ll%] with a negative 
exercise test response, angina developed. This was 
secondary to restenosis at a prior angioplasty dilatation 
site in 2 patients and related to multivessel disease in 
the other patients. Two patients underwent repeat cor- 
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gery. In the group of patients with positive exercise test 
results, 2 have had angina and have undergone coro- 
nary angioplasty. A maximal exercise test was per- 
formed in 34 patients at 4 to 6 weeks after hospital 
discharge. Of the 36 patients with in-hospital negative 
results, 27 performed a maximal exercise test and 4 
patients (15%) had provokable ischemia. No patient 
who underwent early exercise testing had ventricu- 
lar arrhythmias or a ventricular aneurysm during 
the follow-up period, as detected by routine Holter 
monitoring, chest roentgoenogram or &dimensional 
echocardiography. 
Discussion 
In this study of patients with AM1 who predomi- 
nantly received reperfusion therapy, we have demon- 
strated that a heart rate-limited exercise test is safe 
and feasible 3 days after admission. Furthermore, the 
exercise test, performed in conjunction with tomo- 
graphic thallium scintigraphy, accurately predicted in- 
hospital adverse clinical outcomes. 
Previous studies have documented the prognostic 
value of predischarge or early limited exercise tread- 
mill testing after AMI.Z-7 However, in these recent 
studies, the exercise test was administered 7 to 14 days 
after the infarct, and none of the patients received 
acute interventional therapy to achieve reperfusion. 
The aggressive approach of early recanalization of the 
infarct vessel has been shown to reduce mortality, im- 
prove ventricular function, limit infarct size,8-11J4 but 
not reduce hospital stay, readmission to the hospital or 
any other variable associated with cost containment. 
Thrombolytic therapy alone has been accompanied by 
a higher rate of postinfarct ischemia and reinfarction 
than conventional treatment.gJ4 The present study was 
not a randomized trial of thrombolysis alone com- 
pared with the integrated approach of thrombolysis 
and mechanical revascularization. Further study is 
needed to determine whether the combined strategy 
compared with lytic therapy alone or conventional 
treatment will lead to a higher proportion of patients 
whose conditions are uncomplicated, who can per- 
form a very early treadmill test and who have a nega- 
tive result for inducible ischemia. 
The safety of this exercise test 3 days after admis- 
sion has been supported in the current study by the 
lack of an adverse outcome during or soon after the test 
in any of the 53 consecutive patients. Concern about 
patients exercising soon after AM1 has stemmed from 
the belief that the heart is susceptible to further injury 
during this period.2 No patient in the current study had 
evidence of ventricular aneurysm formation, exten- 
sion of the infarction or precipitation of malignant 
ventricular arrhythmias. Our observation of safety 
may be limited by type II error, and careful confirma- 
tion of these results are important before more wide- 
spread use can be recommended. 
The exercise test provides an objective assessment 
of the patient’s functional capacity before discharge. It 
could be argued that the coronary anatomy was de- 
fined by emergency angiography in most patients in 
the current trial, precluding the need for an exercise 
study. However, in 5 of 14 patients (36%) with a posi- 
tive early exercise test response, the infarct vessel had 
been recanalized with thrombolysis and balloon dila- 
tation with less than a 50% residual stenosis. On the 
other hand, in 9 of the 36 patients (25%] with a negative 
test response, the infarct vessel had a significant resid- 
ual stenosis (70% or greater) at the end of the emergen- 
cy catheterization, Thus, early exercise testing provid- 
ed ancillary data regarding the potential to provoke 
ischemia that did not accurately reflect the findings of. 
emergency angiography. 
A heart rate-limited rather than a symptom-limited 
test was used in the present study because of the po- 
tential to induce an adverse clinical outcome, even 
though the latter approach has been shown to have a 
greater prognostic yield when performed at 1 to 2 
weeks.zJj In patients who underwent a follow-up max- 
imal exercise test 4 to 6 weeks after the event, the lack 
of early exercise test sensitivity for detecting ischemia 
became apparent in 15% of patients whose test re- 
sponse became positive. An alternative to exercise 
testing in this very early time frame may be the admin- 
istration of intravenous dipyridamole with accompa- 
nying electrocardiography and thallium scintigraphy, 
which have been shown to have a high yield in detect- 
ing provokable ischemia in the peri-infarct setting-l5 
The safety and predictive value of a negative early 
treadmill test demonstrate the potential for early hos- 
pital discharge 3 days after AMI. Although only one- 
third of patients in the present study had a negative 
early exercise test response, this represents a sub- 
set with substantial cost-saving potential for reducing 
the overall length of stay. Recent randomized trials 
have focused on early vs conventional hospital dis- 
charge,16J7 and the conventional length of stay after 
AM1 has decreased from 3 weeks to approximately 7 
days in the past 10 years. In the current study, patients 
with uncomplicated AM1 and a negative early exer- 
cise test result were monitored in the hospital and 
discharged at 7 to 10 days. Although careful prospec- 
tive randomized studies are necessary to validate long- 
term safety and feasibility of this approach, the current 
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FIGURE 3. Results of acute intervention for meeting uncomplicated 
criteria, performing an exercise treadmill test (ElT), and having a 
negative exercise test result. MI = myocardlal infarction; PTCA = 
percutaneous transluminal coronary angioplasty. 
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patients with AM1 for early hospital discharge with its 
attendant savings in cost. 
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